BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 20623990)

  • 1. Stem cell therapies to treat muscular dystrophy: progress to date.
    Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
    BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of stem cells in muscular dystrophies.
    Meregalli M; Farini A; Colleoni F; Cassinelli L; Torrente Y
    Curr Gene Ther; 2012 Jun; 12(3):192-205. PubMed ID: 22463740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies.
    Salani S; Donadoni C; Rizzo F; Bresolin N; Comi GP; Corti S
    J Cell Mol Med; 2012 Jul; 16(7):1353-64. PubMed ID: 22129481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotent Stem Cells for Gene Therapy of Degenerative Muscle Diseases.
    Loperfido M; Steele-Stallard HB; Tedesco FS; VandenDriessche T
    Curr Gene Ther; 2015; 15(4):364-80. PubMed ID: 26122099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives of stem cell therapy in Duchenne muscular dystrophy.
    Meregalli M; Farini A; Belicchi M; Parolini D; Cassinelli L; Razini P; Sitzia C; Torrente Y
    FEBS J; 2013 Sep; 280(17):4251-62. PubMed ID: 23206279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining stem cells and exon skipping strategy to treat muscular dystrophy.
    Meregalli M; Farini A; Torrente Y
    Expert Opin Biol Ther; 2008 Aug; 8(8):1051-61. PubMed ID: 18613758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell-based therapies for Duchenne muscular dystrophy.
    Sun C; Serra C; Lee G; Wagner KR
    Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell therapy strategies and improvements for muscular dystrophy.
    Quattrocelli M; Cassano M; Crippa S; Perini I; Sampaolesi M
    Cell Death Differ; 2010 Aug; 17(8):1222-9. PubMed ID: 19876070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoblast transfer therapy: is there any light at the end of the tunnel?
    Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
    Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise review: stem cell therapy for muscular dystrophies.
    Wilschut KJ; Ling VB; Bernstein HS
    Stem Cells Transl Med; 2012 Nov; 1(11):833-42. PubMed ID: 23197695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advances in cell therapy strategies for muscular dystrophies.
    Negroni E; Vallese D; Vilquin JT; Butler-Browne G; Mouly V; Trollet C
    Expert Opin Biol Ther; 2011 Feb; 11(2):157-76. PubMed ID: 21219234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell based therapies to treat muscular dystrophy.
    Price FD; Kuroda K; Rudnicki MA
    Biochim Biophys Acta; 2007 Feb; 1772(2):272-83. PubMed ID: 17034994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-derived stem cells: potential for muscle regeneration.
    Huard J; Cao B; Qu-Petersen Z
    Birth Defects Res C Embryo Today; 2003 Aug; 69(3):230-7. PubMed ID: 14671776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into skeletal muscle development and applications in regenerative medicine.
    Tran T; Andersen R; Sherman SP; Pyle AD
    Int Rev Cell Mol Biol; 2013; 300():51-83. PubMed ID: 23273859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell therapy for muscular dystrophies.
    Biressi S; Filareto A; Rando TA
    J Clin Invest; 2020 Nov; 130(11):5652-5664. PubMed ID: 32946430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation.
    Goudenege S; Lebel C; Huot NB; Dufour C; Fujii I; Gekas J; Rousseau J; Tremblay JP
    Mol Ther; 2012 Nov; 20(11):2153-67. PubMed ID: 22990676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].
    Nishiyama T; Takeda S
    Brain Nerve; 2012 Jan; 64(1):39-46. PubMed ID: 22223500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.
    Ostrovidov S; Shi X; Sadeghian RB; Salehi S; Fujie T; Bae H; Ramalingam M; Khademhosseini A
    Stem Cell Rev Rep; 2015 Dec; 11(6):866-84. PubMed ID: 26323256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myogenic Progenitors from Mouse Pluripotent Stem Cells for Muscle Regeneration.
    Magli A; Incitti T; Perlingeiro RC
    Methods Mol Biol; 2016; 1460():191-208. PubMed ID: 27492174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of human myogenic progenitors from pluripotent stem cells for in vivo regeneration.
    Kim H; Perlingeiro RCR
    Cell Mol Life Sci; 2022 Jul; 79(8):406. PubMed ID: 35802202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.